CO5690582A2 - Derivados de n-tiazol-2-il-benzamida - Google Patents
Derivados de n-tiazol-2-il-benzamidaInfo
- Publication number
- CO5690582A2 CO5690582A2 CO06039105A CO06039105A CO5690582A2 CO 5690582 A2 CO5690582 A2 CO 5690582A2 CO 06039105 A CO06039105 A CO 06039105A CO 06039105 A CO06039105 A CO 06039105A CO 5690582 A2 CO5690582 A2 CO 5690582A2
- Authority
- CO
- Colombia
- Prior art keywords
- alkyl
- alkoxy
- cycloalkyl
- halogen
- hydrogen
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D277/00—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings
- C07D277/02—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings
- C07D277/20—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
- C07D277/32—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D277/38—Nitrogen atoms
- C07D277/44—Acylated amino or imino radicals
- C07D277/46—Acylated amino or imino radicals by carboxylic acids, or sulfur or nitrogen analogues thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A61K31/425—Thiazoles
- A61K31/426—1,3-Thiazoles
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/08—Antiepileptics; Anticonvulsants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
- A61P25/16—Anti-Parkinson drugs
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/24—Antidepressants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Neurology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Biomedical Technology (AREA)
- Neurosurgery (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Psychiatry (AREA)
- Epidemiology (AREA)
- Pain & Pain Management (AREA)
- Psychology (AREA)
- Cardiology (AREA)
- Heart & Thoracic Surgery (AREA)
- Hospice & Palliative Care (AREA)
- Urology & Nephrology (AREA)
- Vascular Medicine (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Thiazole And Isothizaole Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
Abstract
1.- Uso de un compuesto de fórmula I:en donde R1 y R6 son, de manera independiente, hidrógeno, alquilo C1-6 o halógeno;R2-R5 se seleccionan de manera independiente entre el grupo que consiste en: hidrógeno, halógeno, ciano, OH, NH2, nitro, alquilo C1-6, arilo, aril-alquiloC1-6, heteroarilalquiloC1-6, cicloalquilo C3-8, cicloalquiloC3-8-alquiloC1-6, alcoxi C1-6, aril-alcoxiC1-6, alquiloC1-6-amino y aril-alquilaminoC1-6, en donde cada alquilo, alcoxi o arilo puede estar opcionalmente sustituido con uno o más halógeno, ciano, alquilo C1-6, alcoxi C1-6 o alcoxiC1-6-alcoxiC1-6;o R4 y R5 juntos son X-(CH2)n-Y, en donde X e Y se seleccionan de modo independiente entre el grupo que consiste en CH2, NH y O; n es 1, 2 ó 3; y R2 y R3 se definen según lo descripto anteriormente;A es *NR8-CO, *CO-NR9, *NR8-CS o *CS-NR9, en donde R8 y R9 se seleccionan de manera independiente entre el grupo que consiste en hidrógeno y alquilo C1-6, o R8 junto con R3 son alquileno C2-3 o CH2CH2O, en donde el oxígeno está unido al anillo fenilo, y el * indica el átomo que está unido al anillo fenilo;y R7 se selecciona entre el grupo que consiste en alquilo C1-8, arilo, heteroarilo, aril-alquiloC1-6, heteroarilalquiloC1-6, cicloalquilo C3-S, cicloalquiloC3-s-alquiloC1-6, alcoxi C1-6, aril-alcoxiC1-6, heteroaril-alcoxiC1-6, alquilaminoC1-6, arilalquilaminoC1-6, heteroaril-alquilaminoC1-6, di-(alquilo C1-6)amino, 2,3-dihidrobenzo-[1,4]dioxin-2-ilo o adamant-1-il-metilo, en donde cada alquilo y cicloalquilo puede estar opcionalmente sustituido con uno o más halógeno, ciano, hidroxi, oxo, alcoxi C1-6 o NR10R11, en donde R10 y R11 en forma independiente son hidrógeno o alquilo C1-6, o R10 y R11 junto con el nitrógeno forman un anillo alifático de 5, 6 ó 7 miembros que en forma opcional puede contener otro heteroátomo seleccionado entre N y O, y cada arilo puede estar opcionalmente sustituido con uno o más halógeno, ciano, hidroxi, nitro, alquilo C1-6, alcoxi C1-6, acilo C1-6, aciloxi C1-6, NR10R11 en donde R10 y R11 en forma independiente son hidrógeno o alquilo C1-6, o R10 y R11 junto con el nitrógeno forman un anillo alifático de 5, 6 ó 7 miembros ...
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| DKPA200301579 | 2003-10-27 | ||
| DKPA200400229 | 2004-02-13 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CO5690582A2 true CO5690582A2 (es) | 2006-10-31 |
Family
ID=34524309
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CO06039105A CO5690582A2 (es) | 2003-10-27 | 2006-04-25 | Derivados de n-tiazol-2-il-benzamida |
Country Status (28)
| Country | Link |
|---|---|
| US (2) | US20060154974A1 (es) |
| EP (2) | EP1803455A1 (es) |
| JP (1) | JP2007509083A (es) |
| KR (1) | KR20060093726A (es) |
| AR (1) | AR047621A1 (es) |
| AT (1) | ATE354365T1 (es) |
| AU (1) | AU2004283019A1 (es) |
| BR (1) | BRPI0415661A (es) |
| CA (1) | CA2542816A1 (es) |
| CO (1) | CO5690582A2 (es) |
| CY (1) | CY1106526T1 (es) |
| DE (1) | DE602004004925T2 (es) |
| DK (1) | DK1682129T3 (es) |
| EA (2) | EA200801734A1 (es) |
| ES (1) | ES2279414T3 (es) |
| HR (1) | HRP20070194T3 (es) |
| IL (1) | IL175189A0 (es) |
| IS (1) | IS8364A (es) |
| ME (1) | MEP6708A (es) |
| MX (1) | MXPA06004436A (es) |
| NO (1) | NO20062417L (es) |
| PL (1) | PL1682129T3 (es) |
| PT (1) | PT1682129E (es) |
| RS (1) | RS20060289A (es) |
| SG (1) | SG147472A1 (es) |
| SI (1) | SI1682129T1 (es) |
| TW (1) | TW200524887A (es) |
| WO (1) | WO2005039572A1 (es) |
Families Citing this family (16)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US20060106040A1 (en) | 2002-12-19 | 2006-05-18 | Michael Grzelak | Adenosine A2a receptor antagonists for the treatment of extra-pyramidal syndrome and other movement disorders |
| TW200524887A (en) * | 2003-10-27 | 2005-08-01 | Lundbeck & Co As H | N-thiazol-2-yl-benzamide derivatives |
| US7910613B2 (en) | 2004-09-22 | 2011-03-22 | H. Lundbeck A/S | 2-acylaminothiazole derivatives |
| US7674912B2 (en) | 2005-04-25 | 2010-03-09 | H. Lundbeck A/S | Pro-drugs of N-thiazol-2-yl-benzamide derivatives |
| TW200720264A (en) * | 2005-04-25 | 2007-06-01 | Lundbeck & Co As H | Pro-drugs of n-thiazol-2-yl-benzamide derivatives |
| JPWO2006137527A1 (ja) * | 2005-06-23 | 2009-01-22 | 協和発酵キリン株式会社 | チアゾール誘導体 |
| CA2617817C (en) | 2005-08-02 | 2014-05-27 | Kyowa Hakko Kogyo Co., Ltd. | Thiazole derivatives for treating or preventing sleep disorders |
| ES2273599B1 (es) | 2005-10-14 | 2008-06-01 | Universidad De Barcelona | Compuestos para el tratamiento de la fibrilacion auricular. |
| EP2210891A1 (en) * | 2009-01-26 | 2010-07-28 | Domain Therapeutics | New adenosine receptor ligands and uses thereof |
| GB201106817D0 (en) | 2011-04-21 | 2011-06-01 | Astex Therapeutics Ltd | New compound |
| RU2483722C1 (ru) * | 2012-05-22 | 2013-06-10 | Автономная Некоммерческая Организация "Научно-Исследовательский Центр Биотехнологии Антибиотиков И Других Биологически Активных Веществ "Биоан" | Аминотиазольные производные усниновой кислоты как новые противотуберкулезные агенты |
| GB201218862D0 (en) | 2012-10-19 | 2012-12-05 | Astex Therapeutics Ltd | Bicyclic heterocycle compounds and their uses in therapy |
| GB201218850D0 (en) | 2012-10-19 | 2012-12-05 | Astex Therapeutics Ltd | Bicyclic heterocycle compounds and their uses in therapy |
| GB201218864D0 (en) | 2012-10-19 | 2012-12-05 | Astex Therapeutics Ltd | Bicyclic heterocycle compounds and their uses in therapy |
| US9980973B2 (en) | 2012-10-19 | 2018-05-29 | Astex Therapeutics Limited | Bicyclic heterocycle compounds and their uses in therapy |
| SG11201604795RA (en) | 2013-12-20 | 2016-07-28 | Astex Therapeutics Ltd | Bicyclic heterocycle compounds and their uses in therapy |
Family Cites Families (12)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE855120C (de) * | 1950-10-08 | 1953-01-05 | Schering Ag | Verfahren zur Herstellung von Aminosalicylsaeureamiden |
| JP2903339B2 (ja) * | 1990-10-12 | 1999-06-07 | 大日精化工業株式会社 | 電子写真感光体 |
| US6121301A (en) * | 1996-10-24 | 2000-09-19 | Zeria Pharmaceutical Co., Ltd. | Substituted benzoylaminothiazole derivatives and drugs containing the same |
| GB9823871D0 (en) * | 1998-10-30 | 1998-12-23 | Pharmacia & Upjohn Spa | 2-Amino-thiazole derivatives, process for their preparation, and their use as antitumour agents |
| GB0028383D0 (en) * | 2000-11-21 | 2001-01-03 | Novartis Ag | Organic compounds |
| EP1354880A4 (en) * | 2001-01-26 | 2004-08-25 | Shionogi & Co | HALOGEN COMPOUNDS HAVING AGONISM TOWARDS THROMBOPOIETIN RECEPTOR |
| US7429593B2 (en) * | 2001-09-14 | 2008-09-30 | Shionogi & Co., Ltd. | Utilities of amide compounds |
| US6624163B2 (en) * | 2001-11-29 | 2003-09-23 | Hoffman-La Roche Inc. | Benzothiazole derivatives |
| US6713499B2 (en) * | 2001-12-12 | 2004-03-30 | Hoffman-La Roche Inc. | 7-Amino-benzothiazole derivatives |
| TW200524887A (en) * | 2003-10-27 | 2005-08-01 | Lundbeck & Co As H | N-thiazol-2-yl-benzamide derivatives |
| EP1700856B1 (en) * | 2003-12-26 | 2015-11-11 | Kyowa Hakko Kirin Co., Ltd. | Thiazole derivative |
| US7674912B2 (en) * | 2005-04-25 | 2010-03-09 | H. Lundbeck A/S | Pro-drugs of N-thiazol-2-yl-benzamide derivatives |
-
2004
- 2004-10-08 TW TW093130498A patent/TW200524887A/zh unknown
- 2004-10-21 AR ARP040103822A patent/AR047621A1/es not_active Application Discontinuation
- 2004-10-25 DK DK04762951T patent/DK1682129T3/da active
- 2004-10-25 JP JP2006535952A patent/JP2007509083A/ja not_active Withdrawn
- 2004-10-25 WO PCT/DK2004/000733 patent/WO2005039572A1/en active IP Right Grant
- 2004-10-25 CA CA002542816A patent/CA2542816A1/en not_active Abandoned
- 2004-10-25 RS YUP-2006/0289A patent/RS20060289A/sr unknown
- 2004-10-25 DE DE602004004925T patent/DE602004004925T2/de not_active Expired - Fee Related
- 2004-10-25 PL PL04762951T patent/PL1682129T3/pl unknown
- 2004-10-25 BR BRPI0415661-7A patent/BRPI0415661A/pt not_active IP Right Cessation
- 2004-10-25 SI SI200430225T patent/SI1682129T1/sl unknown
- 2004-10-25 EA EA200801734A patent/EA200801734A1/ru unknown
- 2004-10-25 ME MEP-67/08A patent/MEP6708A/xx unknown
- 2004-10-25 ES ES04762951T patent/ES2279414T3/es active Active
- 2004-10-25 PT PT04762951T patent/PT1682129E/pt unknown
- 2004-10-25 EP EP07102639A patent/EP1803455A1/en not_active Withdrawn
- 2004-10-25 EA EA200600860A patent/EA010790B1/ru not_active IP Right Cessation
- 2004-10-25 EP EP04762951A patent/EP1682129B1/en active Active
- 2004-10-25 AT AT04762951T patent/ATE354365T1/de not_active IP Right Cessation
- 2004-10-25 KR KR1020067008181A patent/KR20060093726A/ko not_active Application Discontinuation
- 2004-10-25 AU AU2004283019A patent/AU2004283019A1/en not_active Abandoned
- 2004-10-25 MX MXPA06004436A patent/MXPA06004436A/es active IP Right Grant
- 2004-10-25 SG SG200807988-1A patent/SG147472A1/en unknown
-
2005
- 2005-12-20 US US11/312,661 patent/US20060154974A1/en not_active Abandoned
-
2006
- 2006-03-20 IS IS8364A patent/IS8364A/is unknown
- 2006-04-25 CO CO06039105A patent/CO5690582A2/es not_active Application Discontinuation
- 2006-04-25 IL IL175189A patent/IL175189A0/en unknown
- 2006-05-26 NO NO20062417A patent/NO20062417L/no not_active Application Discontinuation
-
2007
- 2007-04-19 CY CY20071100529T patent/CY1106526T1/el unknown
- 2007-05-07 HR HR20070194T patent/HRP20070194T3/xx unknown
-
2008
- 2008-12-19 US US12/339,438 patent/US20090247593A1/en not_active Abandoned
Also Published As
| Publication number | Publication date |
|---|---|
| TW200524887A (en) | 2005-08-01 |
| EA200801734A1 (ru) | 2008-12-30 |
| JP2007509083A (ja) | 2007-04-12 |
| KR20060093726A (ko) | 2006-08-25 |
| CY1106526T1 (el) | 2012-01-25 |
| EA010790B1 (ru) | 2008-10-30 |
| HRP20070194T3 (en) | 2007-06-30 |
| US20060154974A1 (en) | 2006-07-13 |
| DE602004004925T2 (de) | 2007-10-31 |
| PT1682129E (pt) | 2007-04-30 |
| DK1682129T3 (da) | 2007-06-11 |
| MEP6708A (xx) | 2010-02-10 |
| EA200600860A1 (ru) | 2006-08-25 |
| EP1682129A1 (en) | 2006-07-26 |
| DE602004004925D1 (de) | 2007-04-05 |
| EP1803455A1 (en) | 2007-07-04 |
| AU2004283019A1 (en) | 2005-05-06 |
| US20090247593A1 (en) | 2009-10-01 |
| NO20062417L (no) | 2006-05-26 |
| PL1682129T3 (pl) | 2007-07-31 |
| EP1682129B1 (en) | 2007-02-21 |
| IL175189A0 (en) | 2006-09-05 |
| WO2005039572A1 (en) | 2005-05-06 |
| CA2542816A1 (en) | 2005-05-06 |
| BRPI0415661A (pt) | 2006-12-19 |
| IS8364A (is) | 2006-03-20 |
| SG147472A1 (en) | 2008-11-28 |
| AR047621A1 (es) | 2006-02-01 |
| ATE354365T1 (de) | 2007-03-15 |
| ES2279414T3 (es) | 2007-08-16 |
| RS20060289A (en) | 2008-06-05 |
| SI1682129T1 (sl) | 2007-06-30 |
| MXPA06004436A (es) | 2006-06-20 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CO5690582A2 (es) | Derivados de n-tiazol-2-il-benzamida | |
| AR050267A1 (es) | Derivados de urea ciclicos sustituidos con heterociclo, su preparacion y su uso farmaceutico como inhibidores de quinasa | |
| AR038703A1 (es) | Derivados de 5-feniltiazol y uso como inhibidor de quinasa p i 3 | |
| AR054529A1 (es) | Derivados de benzazepina como moduladores del receptor de 5-hidroxi-triptamina 6 | |
| AR054130A1 (es) | Procedimiento para la preparacion de 1-alquil-3-feniluracilos | |
| AR061946A1 (es) | Derivados de n-(amino-heteroaril)-1h-indol-2-carboxamidas, su preparacion y composiciones farmaceuticas | |
| AR047817A1 (es) | Derivados de aril- y heteroarilpiperidincarboxilatos, su preparacion y su aplicacion en terapeutica | |
| CO5690596A2 (es) | Derivados de hexahidropirazino [1,2-a]pirimidin-4,7-diona sustituidos, en el nitrogeno, metodo para su produccion y su uso como medicamentos | |
| AR077598A1 (es) | Compuestos heterociclicos fusionados como modulares de canales ionicos | |
| AR050181A1 (es) | Derivados de urea ciclicos sustituidos, su preparacion y su uso farmaceutico como inhibidores de quinasa | |
| PE20030890A1 (es) | Cumarinas utiles como biomarcadores | |
| ECSP055883A (es) | Nuevos derivados de piridazin-3(2h)-ona | |
| CO5601018A2 (es) | Derivados de n-fenil-2-pirimidin-amina | |
| AR049543A1 (es) | Derivados de la 1-amino-ftalazina, su preparacion y su aplicacion en terapeutica | |
| PE20080067A1 (es) | DERIVADOS DE TRIAZOLOPIRAZINA COMO MODULADORES DEL RECEPTOR DEL FACTOR DE CRECIMIENTO DE HEPATOCITO (c-MET O HGFR) | |
| AR055150A1 (es) | Compuestos de isoindol - imido y composiciones que los comprenden y sus metodos de uso | |
| CO6150140A2 (es) | Inhibidores de proteina tirosina fosfatasa humana y metodos de uso | |
| CO6241101A2 (es) | Derivados de quinolina como inhibidores de la p13 quinasa | |
| ES2203988T3 (es) | Compuestos de pirimidinona y composiciones farmaceuticas que los contienen. | |
| SE0101579D0 (sv) | New compounds | |
| CO5601021A2 (es) | Derivados de quinazolinona, composiciones farmaceuticas que los contienen y su proceso de preparacion y su uso como antagonistas cb | |
| AR055666A1 (es) | Inhibidores inntr | |
| AR039111A1 (es) | Tiopirimidinas e isotiazolpirimidinas inhibidoras de quinasas | |
| AR070438A1 (es) | Derivados de 3- aminoalquil -1,3- dihidro -2h indol-2- ona su preparacion y su aplicacion en terapeutica | |
| AR039122A1 (es) | Derivados de ftalimido como inhibidores de monoamino oxidasa b |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FC | Application refused |